NovAliX and Inventiva Form a Strategic Alliance on Nuclear Receptors

News   Apr 09, 2013

 
NovAliX and Inventiva Form a Strategic Alliance on Nuclear Receptors
 
 
 
 

RELATED ARTICLES

Easily Automate PK Assays for Human IgG Drugs in Preclinical Species

News

At AAPS NBC event, Lumigen produced a poster summarizing the use of their pipetting robot, Andrew which can measure IgG drug concentration in a pre-clinical setting.

READ MORE

Could This Be a "Silver Bullet" for Preventing and Treating Colon Cancer?

News

A team of scientists targeted the gene CtBP with a drug known as HIPP (2-hydroxy-imino phenylpyruvic acid) and were able to reduce the development of pre-cancerous polyps by half.

READ MORE

A Rogue Gene is Causing Seizures in Babies. Here’s How MSU Wants to Stop it

News

The researchers are closer to understanding the source of the seizures, a gene known as GNAO1 and the transformations it can take on, and potentially stopping its devastating effects by uncovering key differences in the way it functions.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE